Skip to main content
Equibles

BARCLAYS PLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 312069 LONDON, X0
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,953,444
+$300,935 QoQ
Shares Held
754,226
+40.1% QoQ
Ownership
0.814%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 179 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. AVXL ranks #79 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in AVXL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,953,444 754,226
2026-03-31 $1,652,509 538,277
2025-12-31 $1,755,692 493,172
2025-09-30 $2,325,391 261,280
2025-06-30 $2,620,866 284,259
2025-03-31 $1,275,631 148,675
2024-12-31 $1,598,144 148,803
2024-09-30 $881,416 155,179
2024-06-30 $384,349 91,078
2024-03-31 $571,362 112,252
2023-12-31 $1,959,103 210,430
2023-09-30 $1,051,779 160,577
2023-06-30 $1,562,186 192,151
2023-03-31 $1,624,983 189,613
2022-12-31 $92,600 10,000
2022-09-30 $1,953,472 189,290
2022-06-30 $100,100 10,000
2022-03-31 $1,476,104 119,911
2021-12-31 $3,335,417 192,354
2021-06-30 $291,875 12,768
2021-03-31 $1,297,225 86,771
2020-12-31 $396,057 73,344
2020-09-30 $369,304 81,166
2020-06-30 $529,318 107,585
2020-03-31 $213,110 67,654